Skip to content
Review Open access

Diagnostic Performance of Initial High-Sensitivity Troponin I in Patients with Renal Dysfunction: A Systematic Review and Narrative Synthesis

Oct 2026 · Medicina · 0 citations · 23 references

Abstract

Background and Objectives: Initial high-sensitivity cardiac troponin I (hs-cTnI) measurements can be difficult to interpret in patients with renal dysfunction because elevated concentrations may occur without acute myocardial infarction (AMI). This systematic review compared reported optimal hs-cTnI cutoffs and their diagnostic performance across assay platforms and patient subgroups. Materials and Methods: PubMed/MEDLINE, Embase, the Cochrane Library, and Web of Science were searched from inception to 21 August 2026. Studies evaluating initial hs-cTnI measurements in adults with renal dysfunction and reporting diagnostic cutoffs with corresponding sensitivity and specificity for AMI were eligible. Risk of bias was assessed using QUADAS-2. Findings were synthesized narratively because of clinical and methodological heterogeneity; no meta-analysis was performed. Results: Five studies were included. In studies analyzing patients with an estimated glomerular filtration rate below 60 mL/min/1.73 m2 as a single group, optimal cutoffs ranged from 25.9 to 54 ng/L, with sensitivities of 76–88.4% and specificities of 83–90%. One study reported substantially higher cutoffs of 500–2610 ng/L across selected subgroups defined by CKD stage, age, and sex, with sensitivities of 80.4–91.4% and specificities of 92.1–100%. In patients receiving dialysis, cutoffs were 75 ng/L for hemodialysis and 144 ng/L for peritoneal dialysis, yielding sensitivities of 93.3% and 100% and specificities of 60.8% and 83.1%, respectively. All five studies were rated as having a high risk of bias in the index test domain. Conclusions: Reported initial hs-cTnI cutoffs varied considerably across assays and patient populations. The available evidence does not establish a single cutoff applicable to all patients with renal dysfunction. These thresholds require external validation and should be interpreted alongside clinical findings and serial troponin measurements.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.